Welcome to LookChem.com Sign In|Join Free
  • or
Ethyl 5-hydroxy-2-(4-methoxyphenyl)benzofuran-3-carboxylate is a complex organic compound with the molecular formula C17H16O6. It is a derivative of benzofuran, a heterocyclic aromatic organic compound consisting of a benzene ring fused to a furan ring. The molecule features a hydroxyl group at the 5-position, a methoxy group at the 4-position on the phenyl ring, and a carboxylate group at the 3-position. ethyl 5-hydroxy-2-(4-methoxyphenyl)benzofuran-3-carboxylate is known for its potential applications in the synthesis of various pharmaceuticals and agrochemicals due to its unique structure and functional groups. It is typically synthesized through multi-step organic reactions and is used as an intermediate in the preparation of more complex molecules.

5010-38-8

Post Buying Request

5010-38-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5010-38-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 5010-38-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,0,1 and 0 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 5010-38:
(6*5)+(5*0)+(4*1)+(3*0)+(2*3)+(1*8)=48
48 % 10 = 8
So 5010-38-8 is a valid CAS Registry Number.

5010-38-8Relevant academic research and scientific papers

Design, Synthesis, and In Vitro Anti-mycobacterial Activities of Propylene Tethered Benzofuran–Isatin Hybrids

Guo, Hua

, p. 338 - 342 (2019)

A series of novel propylene tethered benzofuran–isatin hybrids 5a–j were designed, synthesized, and assessed for their in vitro anti-mycobacterial activity against Mycobacterium tuberculosis (MTB) H37Rv and multidrug-resistant (MDR)-MTB strains

Design, synthesis and in vitro anti-bacterial activities of benzofuran-isatin hybrids

Wang, Yin-Ling,Zhao, Shi-Jia,Liu, Yi,Xu, Zhi

, p. 687 - 710 (2021/02/06)

A series of novel benzofuran-isatin hybrids 6a-x tethered through propylene, butylene, pentylene and hexylene were designed, synthesized and evaluated for their in vitro antibacterial activities against a panel of clinically important Gram-positive and Gr

Benzofuran-isatin conjugates as potent VEGFR-2 and cancer cell growth inhibitors

Zou, Yulin

, p. 510 - 516 (2019/11/19)

A series of benzofuran-isatin conjugates 6a-l and 7a,b tethered by various alkyl linkers were synthesized and evaluated for their VEGFR-2 inhibitory activity and in vitro activity against a panel of cancer cell lines. Seven of them were comparable with or

Benzofuran-isatin-imine hybrids tethered via different length alkyl linkers: Design, synthesis and in vitro evaluation of anti-tubercular and anti-bacterial activities as well as cytotoxicity

Gao, Feng,Wang, Tengfei,Gao, Meixiang,Zhang, Xia,Liu, Zhuqing,Zhao, ShiJia,Lv, ZaoSheng,Xiao, Jiaqi

, p. 323 - 331 (2019/01/30)

Herein we report the design and synthesis of twenty-two novel benzofuran-isatin-imine hybrids 7a-v tethered through propylene, butylene, pentylene and hexylene, and for the evaluation of their in vitro anti-tubercular and anti-bacterial activities as well

Benzofuran-isatin hybrids tethered via different length alkyl linkers and their in vitro anti-mycobacterial activities

Gao, Feng,Chen, Zijian,Ma, Long,Qiu, Lin,Lin, Jianguo,Lu, Guangming

, p. 2652 - 2656 (2019/04/17)

A series of novel benzofuran-isatin hybrids 6a–m tethered through different length alkyl linkers propylene, butylene, pentylene and hexylene were designed, synthesized and evaluated for their in vitro anti-mycobacterial activities against both drug-suscep

Benzofuran-isatin-hydroxylimine/thiosemicarbazide hybrids: Design, synthesis and in vitro anti-mycobacterial activity evaluation

Zhang, Yaohuan,Wang, Ruo,Zhang, Tesen,Yan, Weitao,Chen, Yihong,Zhang, Yanping,Zhou, Muyang

, p. 653 - 655 (2019/01/04)

A series of novel benzofuran-isatin-hydroxylimine/thiosemicarbazide hybrids were designed, synthesized and evaluated for their in vitro anti-TB activities against drug-sensitive MTB H37Rv and MDR-TB isolates as well as cytotoxicity. All benzofu

Benzofuran–isatin Hybrids: Design, Synthesis, and In Vitro Anti-cancer Activities

Diao, Quan-Ping,Guo, Hua,Wang, Gang-Qiang

, p. 1687 - 1693 (2019/04/08)

A series of novel benzofuran–isatin hybrids 6a–s tethered through propylene and butylene were designed, synthesized, and evaluated for their in vitro anti-cancer activities against HepG2 (liver carcinoma), Hela (cervical cancer), A549 (lung adenocarcinoma

Design, synthesis and in vitro anti-bacterial activities of benzofuran-isatin hybrids

Wang, Yin-Ling,Zhao, Shi-Jia,Liu, Yi,Xu, Zhi

, p. 687 - 710 (2019/11/19)

A series of novel benzofuran-isatin hybrids 6a-x tethered through propylene, butylene, pentylene and hexylene were designed, synthesized and evaluated for their in vitro antibacterial activities against a panel of clinically important Gram-positive and Gr

Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis

Zhang, Wei,Lun, Shichun,Wang, Shu-Huan,Jiang, Xing-Wu,Yang, Fan,Tang, Jie,Manson, Abigail L.,Earl, Ashlee M.,Gunosewoyo, Hendra,Bishai, William R.,Yu, Li-Fang

, p. 791 - 803 (2018/02/17)

Inhibition of the mycolic acid pathway has proven a viable strategy in antitubercular drug discovery. The AccA3/AccD4/FadD32/Pks13 complex of Mycobacterium tuberculosis constitutes an essential biosynthetic mechanism for mycolic acids. Small molecules targeting the thioesterase domain of Pks13 have been reported, including a benzofuran-based compound whose X-ray cocrystal structure has been very recently solved. Its initial inactivity in a serum inhibition titration (SIT) assay led us to further probe other structurally related benzofurans with the aim to improve their potency and bioavailability. Herein, we report our preliminary structure-activity relationship studies around this scaffold, highlighting a natural product-inspired cyclization strategy to form coumestans that are shown to be active in SIT. Whole genome deep sequencing of the coumestan-resistant mutants confirmed a single nucleotide polymorphism in the pks13 gene responsible for the resistance phenotype, demonstrating the druggability of this target for the development of new antitubercular agents.

Design, synthesis and anti-mycobacterial activity evaluation of benzofuran-isatin hybrids

Gao, Feng,Yang, Hua,Lu, Tianyu,Chen, Zijian,Ma, Long,Xu, Zhi,Schaffer, Paul,Lu, Guangming

, p. 277 - 281 (2018/10/15)

Herein we report the design and synthesis of a series of novel benzofuran-isatin hybrids, and in vitro evaluation of their anti-mycobacterial activity against both drug-susceptible and multi-drug resistant (MDR) Mycobacterium tuberculosis (MTB) strains. I

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5010-38-8